GlaxoSmithKline announced today, 10/11/2012, that they will make all clinical trial data available to researchers in their effort to become a more transparent company. This move could have a positive effect on clinical oncology practice.

Dr. Janice Dutcher has moved her clinical practice and IL-2 treatment program from the Montefiore Medical Center in the Bronx to the St. Luke’s Roosevelt Hospital Center in Manhattan where Dr. Dutcher is the Director of the Immunotherapy Program.

Stanford University researchers have discovered a molecule that directly attacks kidney cancer cells that have the VHL tumor-suppressor gene mutated or disabled. VHL deficient genes are present in 85-90% of clear cell carcinoma, the most prevalent type of kidney cancer.

ACKC announced the launch of a new website and online community to raise awareness of kidney cancer with the goal of raising funds for kidney cancer research and educating Congress about the need for more research funding.

The International Kidney Cancer Coalition (IKCC) hosted its first Annual Conference, “Expanding Circles,” which took place from September 10-13, 2010 in Frankfurt, Germany.